The mitochondrial chaperone HSPD1 folds MTHFD2 independently of its co-chaperone HSPE1

This study identifies MTHFD2 as a direct client of the mitochondrial chaperone HSPD1, demonstrating that HSPD1 facilitates MTHFD2 folding and stability independently of its co-chaperone HSPE1, thereby revealing distinct biological functions for these two proteins in metabolic regulation and tissue-specific stress responses.

The Gist

Imagine your cells are bustling, high-tech factories. Inside these factories, there's a specialized department called the Mitochondria (the power plant), where thousands of tiny machines (proteins) are built to keep the cell running.

But here's the problem: These machines are built in the wrong place (the cytosol) and arrive at the power plant as crumpled, tangled balls of yarn. Before they can work, they need to be unfolded and carefully rewound into their perfect, functional shapes.

Enter the Chaperones. Think of them as the factory's "folding experts" or "tailors." Their job is to take these tangled yarns and fold them into working machines.

The Main Characters

In this story, we have two main tailors who usually work as a team:

1. HSPD1 (The Master Tailor): A large, barrel-shaped machine that does the heavy lifting of folding.
2. HSPE1 (The Assistant): A small lid that usually sits on top of the Master Tailor, helping it close the door and finish the job.

For decades, scientists thought these two were inseparable partners. They believed the Master Tailor couldn't do its job without the Assistant's lid.

The Big Discovery

This paper tells the story of how the scientists found out that the Master Tailor is actually much more independent than we thought.

1. The Mystery Client: MTHFD2
The researchers were looking for a specific machine that the Master Tailor (HSPD1) was responsible for fixing. They found a very important machine called MTHFD2.

• What does MTHFD2 do? It's like the factory's "fuel and ammo maker." It produces the raw materials needed to build DNA (for cell division) and antioxidants (to stop the factory from rusting).
• The Problem: When the scientists removed the Master Tailor (HSPD1) from the factory, the MTHFD2 machine didn't just stop working; it fell apart and was thrown in the trash. The factory couldn't make fuel or ammo anymore.

2. The "Lid" Surprise
Here is the twist: The scientists tested if the Master Tailor needed the Assistant (HSPE1) to fix MTHFD2.

• The Expectation: They thought, "If we remove the Assistant, the Master Tailor will fail, and MTHFD2 will break."
• The Reality: They removed the Assistant, but the Master Tailor kept folding MTHFD2 perfectly fine!
• The Analogy: It's like a master chef who usually uses a specific pot lid to cook a soup. The scientists took the lid away, expecting the soup to burn. Instead, the chef just cooked the soup without the lid, and it turned out delicious. The Master Tailor can do this specific job alone.

3. The "Trash Can" (LONP1)
When the Master Tailor was missing, the MTHFD2 machine didn't just sit there; it got recognized as "broken junk" by the factory's trash collector (a protein called LONP1). The trash collector immediately grabbed the unfolded MTHFD2 and threw it away. This explains why the factory ran out of fuel when the Master Tailor was gone.

The "Twin" Theory Proven Wrong

The paper also looked at what happens when you remove the Master Tailor vs. when you remove the Assistant.

• The Old Theory: Since they work together, removing either one should cause the same chaos in the factory.
• The New Reality: The chaos was totally different!
  • Removing the Master Tailor: The factory stopped making fuel (DNA building blocks) and started rusting (oxidative stress).
  • Removing the Assistant: The factory had different problems, mostly related to how it burned fat for energy.
  • The Metaphor: It's like removing the CEO of a company vs. removing the Head of HR. Both are important, but the company collapses in completely different ways. They aren't just a team; they have their own unique, separate jobs.

Proof from the Animal Kingdom

To make sure this wasn't just a fluke in human cells, the scientists looked at tiny worms (C. elegans).

• When they removed the worm's version of the Master Tailor, the worm's gut (stomach) started screaming for help (stress response).
• When they removed the worm's version of the Assistant, the worm's muscles started screaming for help.
• The Takeaway: Even in nature, these two proteins have evolved to protect different parts of the body. They are not just a single unit; they are two distinct guardians.

Why Does This Matter?

This is huge for cancer research. Cancer cells are like factories running at 100% speed, churning out massive amounts of MTHFD2 to build new cancer cells. They rely heavily on the Master Tailor (HSPD1) to keep this machine running.

If we can trick the cancer cell into thinking the Master Tailor is missing, the MTHFD2 machine breaks, the cancer runs out of fuel, and the cell dies. But because the Master Tailor can work without the Assistant, we might be able to target the Master Tailor specifically without accidentally messing up the Assistant's other jobs.

In short: The "Master Tailor" (HSPD1) is a superhero who can fold a critical machine (MTHFD2) all by himself, without needing his usual sidekick (HSPE1). This changes how we understand how cells work and opens new doors for fighting cancer.

Technical Summary

1. Problem Statement

Mitochondrial proteins are synthesized in the cytosol and imported into the mitochondria in an unfolded state, requiring a network of chaperones for correct folding. While the HSPD1 (HSP60) and HSPE1 (HSP10) complex is known to function as a chaperonin (analogous to bacterial GroEL/GroES) to facilitate protein folding, several critical questions remain unanswered:

• Specificity: Which specific mitochondrial client proteins strictly depend on HSPD1 for folding versus general mitochondrial health?
• Mechanism: Does HSPD1 require its canonical co-chaperone HSPE1 to fold all its clients, or can it function independently for specific substrates?
• Functional Divergence: Do HSPD1 and HSPE1 share identical biological functions, or do they regulate distinct subsets of proteins and metabolic pathways?

2. Methodology

The authors employed a multi-disciplinary approach combining proteomics, molecular biology, in vitro biochemistry, and in vivo models:

• Proteomics (SILAC): Stable Isotope Labeling by Amino acids in Cell culture (SILAC) was used to compare mitochondrial protein solubility and abundance between HSPD1 knockdown (KD) cells and controls. Mitochondria were isolated via anti-TOM22 magnetic beads.
• Bioinformatics & Prioritization: Downregulated proteins were cross-referenced with cancer expression data (TCGA) and co-expression networks (ARCHS4) to prioritize high-confidence clients.
• Validation:
  • Western Blot & qRT-PCR: To distinguish between transcriptional regulation and post-translational protein stability.
  • Proximity Ligation Assay (PLA): To visualize physical proximity (<40 nm) between HSPD1 and client proteins in intact cells and tumor tissues.
  • Metabolomics: Targeted metabolomics (LC-MS) to quantify S-Adenosylmethionine (SAM) and other metabolites.
  • ROS & Respiration: Flow cytometry for Reactive Oxygen Species (ROS) and Seahorse XF for mitochondrial respiration.
• In Vitro Folding Assay: Recombinant MTHFD2 was chemically unfolded (acid treatment) and refolded in the presence of HSPD1, with or without HSPE1. Enzymatic activity was measured to assess folding success.
• Degradation Studies: Cycloheximide (CHX) chase assays to measure protein half-life, and siRNA-mediated KD of mitochondrial proteases (LONP1, CLPP) to identify degradation machinery.
• Transcriptomics (RNA-seq): Comparative analysis of transcriptional responses to HSPD1 vs. HSPE1 KD.
• In Vivo Models:
  • Xenografts: A549 tumor growth in NOD-SCID mice.
  • C. elegans: CRISPR-generated knockouts of hsp-60 and hsp-10 crossed with a UPRmt reporter strain (hsp-6::GFP) to map tissue-specific stress responses.

3. Key Contributions

1. Identification of MTHFD2 as a Direct Client: The study identifies Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2), a key enzyme in the mitochondrial one-carbon (1C) pathway, as a specific, essential client of HSPD1.
2. HSPE1-Independent Folding: The paper provides definitive evidence that HSPD1 can directly fold MTHFD2 in vitro and maintain its expression in vivo without the co-chaperone HSPE1.
3. Mechanism of Degradation: The study elucidates that in the absence of HSPD1, misfolded MTHFD2 is targeted for degradation by the mitochondrial protease LONP1, not CLPP.
4. Functional Divergence: The research demonstrates that HSPD1 and HSPE1 regulate distinct biological pathways and elicit divergent transcriptional and metabolic responses, challenging the view that they function solely as a unified complex.

4. Key Results

• Proteomic Screening: SILAC analysis of HSPD1 KD cells revealed 107 downregulated mitochondrial proteins. MTHFD2 was ranked #3 in co-expression with HSPD1 and #1 in cancer expression.
• Validation of MTHFD2 Dependence:
  • HSPD1 KD reduced MTHFD2 protein levels but not mRNA levels, indicating post-translational instability.
  • MTHFD2 levels were restored in HSPD1 KD cells when LONP1 was simultaneously knocked down, confirming LONP1-mediated degradation of the misfolded protein.
  • PLA confirmed HSPD1 and MTHFD2 interact within the mitochondrial matrix in both cell lines and tumor tissues.
• Metabolic Consequences: HSPD1 KD led to:
  • Reduced S-Adenosylmethionine (SAM) levels (a key 1C pathway output).
  • Increased Reactive Oxygen Species (ROS).
  • No global collapse of mitochondrial mass or basal respiration (in U251 cells), suggesting specific client failure rather than total organelle dysfunction.
• In Vitro Folding: Recombinant HSPD1 successfully refolded acid-denatured MTHFD2, restoring enzymatic activity. Crucially, this occurred independently of HSPE1.
• HSPE1 KD vs. HSPD1 KD:
  • KD of HSPE1 did not reduce MTHFD2 levels.
  • Transcriptomics: RNA-seq showed <10% overlap in differentially expressed genes between HSPD1 and HSPE1 KD. HSPD1 KD affected oxidative stress pathways; HSPE1 KD affected RNA processing.
  • Metabolomics: HSPD1 KD impacted Purine Metabolism (1C pathway); HSPE1 KD impacted Glycerophospholipid Metabolism and $\beta$-oxidation.
• C. elegans Phenotypes:
  • hsp-60 (HSPD1) KO: Triggered the Mitochondrial Unfolded Protein Response (UPRmt) specifically in the gut.
  • hsp-10 (HSPE1) KO: Triggered UPRmt specifically in muscle tissue.
  • This tissue-specific divergence confirms that the two proteins have evolved distinct, non-redundant roles in a whole organism.

5. Significance

• Redefining Chaperone Networks: The findings challenge the dogma that HSPD1 and HSPE1 function strictly as a mandatory complex for all substrates. It establishes that HSPD1 possesses substrate-specific autonomy.
• Cancer Metabolism: Since MTHFD2 is essential for cancer cell proliferation (providing nucleotides and SAM), HSPD1 emerges as a critical upstream regulator of the 1C pathway. Targeting HSPD1 could disrupt tumor metabolism more effectively than targeting MTHFD2 directly, potentially bypassing drug resistance mechanisms.
• Therapeutic Implications: The distinct functional roles of HSPD1 and HSPE1 suggest that therapeutic strategies targeting the chaperone system must be specific. Inhibiting HSPD1 may selectively collapse the 1C pathway in tumors, while HSPE1 inhibition might affect different metabolic processes (e.g., lipid oxidation).
• Evolutionary Insight: The divergent tissue-specific stress responses in C. elegans suggest that HSPD1 and HSPE1 have evolved to manage proteostasis in specific biological contexts, rather than acting as a generic, interchangeable pair.

In conclusion, this paper provides a mechanistic link between the mitochondrial chaperone HSPD1 and the metabolic enzyme MTHFD2, demonstrating a unique, HSPE1-independent folding mechanism with profound implications for mitochondrial proteostasis and cancer metabolism.